
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
The success of antiretroviral medications in controlling HIV disease has been the hallmark of the last decade of the AIDS pandemic, but new studies show that some of the medications may not only treat HIV disease, they may actually prevent HIV infections in the first place. Human studies are already being conducted to gauge the effectiveness of Gilead Sciences' nucleotide analog Viread in preventing HIV infections. But a new monkey study shows that Viread when combined with Gilead's nucleoside analog Emtriva (sold together in the combination pill Truvada) was 100% effective in blocking rectal HIV infections, even in animals exposed to the virus twice daily for a week. The study data are so encouraging that the human trials have been expanded to include both anti-HIV medications and enlarged to enroll more participants. It's not yet clear who might best benefit from Truvada preexposure prophylaxis'although sexually active gay men would likely be an early target group'or even how often the drugs would need to be taken--some scientists say a once-weekly dose may be possible. And there are concerns that a preventative pill could fuel an explosion in unprotected sex among high-risk individuals. But even in light of these unanswered questions and potential pitfalls, study results so far have produced a rare sense of enthusiasm among notoriously cautious AIDS experts. 'This is the first thing I've seen at this point that I think really could have a prevention impact,' says long-time federal AIDS researcher Thomas Folks. 'If it works, it could be distributed quickly and could blunt the epidemic.'
DON'T MISS THE OUT100 SPECIAL 3 DAY MARATHON STARTING NOVEMBER 24TH!
Journey through the year’s influential Out100 – the most iconic and long-standing celebration of LGBTQ+ icons and allies – in a 1-hour television special spotlighting the LGBTQ+ people shaping the world today.
WATCH & LIVESTREAM ON ADVOCATECHANNEL.COM
AND ON THE ADVOCATE CHANNEL APP
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Plus: Featured Video
Latest Stories
7 Uplifting Films To Celebrate Trans Awareness Week & Where To Stream Them
November 17 2023 10:25 AM
Out's Deal Guide: Grab Your 50% Off Amazon Fire Tablets & More Recommended Deals on Amazon Today!
November 03 2023 3:44 PM
Unlock Massive Savings at 'The Holiday Shop': Amazon's Hottest Deals of the Season Await!
November 02 2023 2:17 PM
Dianne Feinstein’s Commitment to People Living With HIV Won’t Be Forgotten
November 02 2023 1:27 PM
PEPFAR in Peril: The Far-Right Wants to End the Lifesaving Global HIV Program
October 24 2023 1:52 PM
Plus Nov/Dec Issue: PEPFAR in Danger & Our Allies and Advocates of the Year
October 23 2023 11:53 AM
Trending stories
Most Recent
Recommended Stories for You
Plus Editors
Editor
Ryan is the Digital Director of The Advocate Channel, and a graduate of NYU Tisch's Department of Dramatic Writing. She is also a member of GALECA, the LGBTQ+ society of entertainment critics. While her specialties are television writing and comedy, Ryan is a young member of the LGBTQ+ community passionate about politics and advocating for all.
Ryan is the Digital Director of The Advocate Channel, and a graduate of NYU Tisch's Department of Dramatic Writing. She is also a member of GALECA, the LGBTQ+ society of entertainment critics. While her specialties are television writing and comedy, Ryan is a young member of the LGBTQ+ community passionate about politics and advocating for all.